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Immunoliposomes, directed to clinically relevant cell-surface molecules with antibodies, antibody fragments or peptides, are used for site-
specific diagnostic evaluation or delivery of therapeutic agents. We have developed intrinsically echogenic liposomes (ELIP) covalently linked to
fibrin(ogen)-specific antibodies and Fab fragments for ultrasonic imaging of atherosclerotic plaques. In order to determine the effect of liposomal
conjugation on the molecular dynamics of fibrinogen binding, we studied the thermodynamic characteristics of unconjugated and ELIP-
conjugated antibody molecules. Utilizing radioimmunoassay and enzyme-linked immunosorbent assay protocols, binding affinities were derived
from data obtained at three temperatures. The thermodynamic functions ΔH°, ΔG° and ΔS° were determined from van't Hoff plots and equations
of state. The resultant functions indicated that both specific and nonspecific associations of antibody molecules with fibrinogen occurred through a
variety of molecular interactions, including hydrophophic, ionic and hydrogen bonding mechanisms. ELIP conjugation of antibodies and Fab
fragments introduced a characteristic change in both ΔH° and ΔS° of association, which corresponded to a variable contribution to binding by
phospholipid gel–liquid crystal phase transitions. These observations suggest that a reciprocal energy transduction, affecting the strength of
antibody–antigen binding, may be a singular characteristic of immunoliposomes, having utility for optimization and further development of the
technology.
© 2007 Elsevier B.V. All rights reserved.Keywords: Immunoliposome; Radioimmunoassay; ELISA; Thermodynamics; Phospholipid phase transition1. Introduction
Immunoliposomes “targeted” to various molecular structures
with specific ligands, such as antibodies and peptides, have
been developed for a number of therapeutic and diagnostic
applications [1–12]. The success of liposomal targeting in these
studies was usually assessed by determination of ligand quantity
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doi:10.1016/j.bbamem.2007.04.007measure of liposomal ligand association with target molecules
(targeting efficiency), and a demonstration of liposomal
targeting within the context of the intended application, in
vitro and/or in vivo. Although immunoliposome affinities have
been measured in several studies [13,14], the effect of liposomal
conjugation on molecular ligand–target interactions has not
been examined.
The measurement and analysis of the thermodynamic
characteristics of noncovalent molecular interactions provides
valuable information, such as the contribution to association
energetics of solvation, protonation, apolar van der Waal's
forces, hydrogen bonds, ionic interactions and motion con-
straints [15–21]. For instance, a two-step kinetic mechanism in
which an initial association of hen egg white lysozyme with its
specific antibody was followed by rearrangement to a more
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determined from surface plasmon resonance (SPR)-derived
affinities [22]. Dissociation kinetics of a self-aggregating
humanized monoclonal antibody specific for vascular endothe-
lial growth factor were determined by size-exclusion high-
pressure liquid chromatography at different temperatures, while
standard thermodynamic functions were calculated from
equations of state, enabling the authors to conclude that ag-
gregation depended largely on hydrophobic interactions [23].
Scatchard analysis of data obtained by radioimmunoassay
(RIA) methods, including double-antibody [24,25] and gel
filtration [26–28] separation protocols, has been employed
frequently for determination of antibody–antigen binding
affinities [29–31]. Enzyme immunoassays, including ELISA,
have also been used to determine affinities, but the validity of
these methods for such purposes has been subject to some
controversy. The method utilized by Edgell et al. [32] for a
direct ELISA aimed to determine apparent dissociation con-
stants (KD) of interactions between antibodies and immobilized
fibrin, which approximates the ultimate application of the
monoclonal antibodies examined. This method, relying on the
hyperbolic function that defines the ELISA dose-response,
requires that the final absorbance values obtained directly
reflect the quantity of antibody bound to the immobilized
antigen, a condition that has been confirmed by several inves-
tigators [33,34]. Underwood [35] criticized the use of direct
ELISA for determining affinities, pointing out that the
secondary enzyme-labeled antibody incubations employed in
most ELISA protocols perturb the equilibrium achieved during
the primary antibody–antigen reactions. This effect could be
normalized, however, through application of equations describ-
ing the phenomenon, provided that the concentration of
immobilized antigen is known.
We have developed intrinsically echogenic liposomes (ELIP)
for diagnostic marker targeting to atheroma in various stages of
development, employing ultrasonic imaging procedures [36],
and subsequently demonstrated effective targeting of echogenic
immunoliposomes (EGIL), produced by conjugating ELIP to
various antibody preparations via a thioether linkage, in vitro
[37] and in vivo [38]. In the latter case, early- and late-stage
atheromas in Yucatan miniswine were highlighted by transvas-
cular and intravascular ultrasound procedures, utilizing ELIP
conjugated to antibodies specific for intercellular adhesion
molecule-1 (ICAM-1) and fibrin(ogen). Optimal fibrin targeting
of ELIP has been quantitatively defined in vitro by retention of
immobilized liposomes in a flow circuit under physiologically
simulated conditions [39].
A better understanding of molecular EGIL-antigen (Ag)
association dynamics may enable optimization of the conjugation
procedure toward improving EGIL targeting efficiency. This
studywas intended to determine the effect of ELIP conjugation on
antifibrin(ogen)–fibrinogen affinities and the thermodynamically
inferred nature of the interactions. The results based on a double-
antibody RIA procedure were compared with those derived from
a direct ELISA, corrected for shifts in equilibrium conditions
during a final secondary antibody–enzyme conjugate incubation.
Clinical applicability of the derived information was tested in apreliminary fashion by repetition of an ELISA study using serum
as the sample diluent.
2. Materials and methods
2.1. Preparation and characterization of EGIL
ELIP, consisting of egg L-α-phosphatidylcholine (PC), 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-[4-(p-maleimidophenyl)butyrate] (MPB-
PE), 1,2 dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG) and cholesterol
(CH) in a 60:8:2:30 or 69:8:8:15 molar ratio, were prepared by a dehydration–
rehydration method and conjugated to proteins as previously described
[36,37,40]. The intact antibodies conjugated were a rabbit polyclonal IgG
fraction that reacts equally well with human fibrin and fibrinogen (PA-fgn), a
mouse monoclonal anti-human fibrin(ogen) with similar cross-reactivity (MA-
fgn) and a mouse monoclonal antibody specific for human fibrin (MA-fb). All
antibody preparations were obtained from American Diagnostica, Inc. (Green-
wich, CN). Thiolated IgG or Fab prepared from 2mg Ab was reacted with 29 mg
ELIP lipid. Fab fragments were prepared from MA-fgn using a commercial kit
(Pierce, Rockford, IL) according to the manufacturer's instructions. For the RIA
studies, conjugation efficiency (CE) was determined by adding a tracer quantity
(3 μCi) of 125I-labeled anti-rabbit Ig to PA-fgn in a typical conjugation protocol
and monitoring activity of column fractions during purification of SPDP-
activated protein, reduced thiolated protein and protein-conjugated ELIP with a
Cobra 5005 Gamma Counting System (Packard Instr. Co., Downers Grove, IL).
For the ELISA studies, CE was determined by a quantitative IgG immunoblot
assay as described by Klegerman et al. [40]. EGIL were sized and enumerated
with a Coulter Multisizer II fitted with a 15 μm aperture tube, which enabled
particle sizing down to 0.3 μm equivalent spherical diameter.
2.2. Radioimmunoassay
For characterization of unconjugated antibody–antigen interactions, a
double-antibody RIA protocol was developed using 125I-fibrinogen (fgn*;
Amersham Life Sci., Arlington Heights, IL), unlabeled human fibrinogen
(Calbiochem-Novabiochem Corp., SanDiego, CA) and specific antibody
(0.1 μg fgn*/μg Ab). For PA-fgn, antibody-bound fibrinogen was separated
from free fibrinogen with goat anti-rabbit gamma globulin, while fibrinogen
bound by MA-fgn and Fab was precipitated with goat anti-mouse gamma
globulin. Precipitation was facilitated by addition of carrier rabbit or mouse
serum. Optimal concentrations of precipitating reagents were specified by the
manufacturer (Calbiochem) or determined in preliminary experiments. Tripli-
cate determinations were made. The time required to attain equilibrium
conditions at three temperatures was determined in preliminary experiments.
These were: 3 days primary Ab incubation+2 days secondary Ab incubation at
4 °C, 2+1 day at 24 °C, and 1 day+overnight at 37 °C. Sodium azide (0.1%)
was included in the incubation buffer at 24 and 37 °C and was shown not to
influence the association behavior of the reaction components.
For RIA of immunoliposomes, EGIL were incubated with fgn* (0.5 μg
EGIL Ab/μg fgn*) in the presence of increasing quantities of unlabeled human
fibrinogen at various temperatures (duplicate determinations: 4 °C for 4 days;
25 °C for 3 days; 37 °C for 2 days). Each reaction solution (1.0 ml) was then
applied to 20 ml of Sepharose 4B in an EconoPac column (Bio-Rad Life Sci.,
Hercules, CA) and eluted with barbital-acetate buffer, pH 7.4. It was established
that EGIL-bound fgn* eluted in the first 8.3 ml and intact free fibrinogen in the
next 7.4 ml. The column flow rate was 56 ml per hour and, therefore, the bound
fraction was recovered within ten min, resulting in negligible underestimation of
this fraction due to the gel filtration method [41].
2.3. ELISA
Wells of immunoassay grade 96-well microtiter plates (Fisher Scientific)
were coated with 50 μg/ml of human fibrinogen (Fgn; Calbiochem) in 0.05 M
sodium bicarbonate, pH 9.6, overnight at 4 °C. All incubation volumes were
50 μl. One well per sample dilution was left uncoated for determination of
nonspecific binding. After aspirating well contents, all wells were blocked with
conjugate buffer (1% bovine serum albumin in 0.05 M Tris buffer, pH 8.0, with
Fig. 1. Correction nomogram for ELISA apparent affinities. Linear regression:
r=0.9998; log y=2.05 log x −0.930.
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(except for thermodynamic studies, where the primary Ab incubation was
carried out at three temperatures), followed by aspiration of well contents and
washes (3×) with PBS-T (0.02M phosphate-buffered saline, pH 7.4, with 0.05%
Tween 20). Half the wells were converted to fibrin by incubating them with 1U/
ml of thrombin in PBS-T with 0.56U aprotinin/ml for 20 min. The remaining
wells (fgn) were incubated with PBS-T alone. For assay of intact EGIL, wells
were washed with PBS after this incubation and the first wash after the EGIL
incubation was also with PBS. Various dilutions of Ab (in PBS-T) or EGIL (in
PBS) were incubated for 2 h, followed by a 1-h incubation with 1:1000
secondary Ab-alkaline phosphatase (AP) in conjugate buffer. The secondary Ab
was goat anti-mouse or anti-rabbit IgG (Bio-Rad Labs). The substrate incubation
consisted of 50 μl of substrate buffer (0.05 M glycine buffer, pH 10.5, with
1.5 mM magnesium chloride)+50 μl p-nitrophenyl phosphate (4 mg/ml; Sigma
Chem. Co.) in substrate buffer per well for 15 min. The reaction was stopped
with 50 μl 1M sodium hydroxide per well. The optical absorbance of each well
at 405 nm (A405) was measured with a Multiskan MCC/340 microplate reader.
Net A405 was determined by subtracting the absorbance of control wells from
that of antigen (Ag) wells.
2.3.1. Serum ELISA study
In order to approximate the effects of in vivo conditions on Ab–Ag binding
characteristics, the ELISA protocol for both unconjugated and ELIP-conjugated
PA-fgn was repeated using undiluted normal rabbit serum (NRS; Sigma-
Aldrich) as sample diluent instead of PBS-T/PBS during the primary Ab
incubation. PBS washes were employed as for EGIL incubations.
2.4. Calculations
2.4.1. RIA studies
For unconjugated antibody,
Bound fgn Bð Þ ¼ Bound fgn*CPM−NSB CPM
Total fgn*CPM−NSB CPM
Total fgn Tð Þ½ ; ð1Þ
where CPM=counts per minute and NSB=nonspecific binding (B CPM at an
excess [100 μg] of unlabeled fgn).
Free fgn ðFÞ ¼ T  B ð2Þ
For EGIL RIA, B was adjusted for the fraction of total I-125 activity
recovered from the column. Scatchard plots were prepared by graphing B/F vs.
B (in molar concentration based on a fgn molecular weight of 340 kDa).
Multiple affinities (Kassoc) were determined from the slopes of discernable linear
segments of the plots. For each affinity, standard enthalpy change, ΔH°, was
determined from the slope of a plot of logK vs. 1/T, according to the van't Hoff
equation, expressed as
log K ¼ DH
-
2:303R
 
1
T
  
þ DS
-
2:303R
ð3Þ
The standard Gibbs free energy increment, ΔG°, was calculated from
DG- ¼ RT 1n K ð4Þ
and the standard entropy change, ΔS°, was then determined from
DG- ¼ DH -  TDS-; ð5Þ
which was verified by comparison with ΔS° derived from the y-intercept of the
van't Hoff plot.
2.4.2. ELISA studies
The dissociation constant (KD) of Ab or EGIL binding to Ag was calculated
according to the equation,
A ¼ Amax ½LðKD þ ½LÞ
 
; ð6Þ
which defines a 2-parameter single rectangular hyperbola, where A=Net A405
and L=Ab [32]; [Ab] for EGIL was calculated from the CE. KD wasdetermined as the average of two computational methods, both performed
using SigmaPlot 2000 software: (a) the b-parameter of a hyperbolic fit of the
data (SPHR), which is the x-intercept of half-maximal y (Amax), and (b) the
slope of a plot of Amax/A vs. 1/[L] (reciprocal plot), based on a linear transform
of the hyperbola:
Amax
A
¼ KD½L þ 1: ð7Þ
For polyclonal Ab, the plot was non-linear and best fit was achieved with a
binomial regression using Sigmaplot 2000 software. The range of affinities was
defined by minimal and maximal slopes from tangents drawn to the curve. In
that case, the arithmetic mean of the range was used as the reciprocal plot KD
value.
The KD values thus obtained were corrected for perturbation of equilibrium
conditions during the secondary Ab–AP incubation, as defined by Underwood
[35]:
b2a½Ab  bfAgþ a½Ab þ KDg þ ½Ag ¼ 0; ð8Þ
where [Ab] is the original total molar Ab concentration in the ELISAwell, [Ag]
is the total molar concentration of Ag epitopes on the solid phase for this
particular Ab, α is the proportion of Ab bound to Ag at equilibrium and β is
the proportion of remaining Ab (α[Ab]) that remains bound after the secondary
Ab–AP incubation. Assuming that α∼0.5 at [Ab]=KD, the equation could be
solved for β at that point, provided [Ag] is known. That value was determined to
be 5 nM for fibrin(ogen) under the conditions of the ELISA from Scatchard
analysis of a solid-phase fibrin-tPA activity assay (SOFIA-tPA) utilizing the
same fgn coating parameters [42]. Since β=A/Amax, apparent KD values were
calculated from equation (6), as
ApparentKD ¼ ½Abb  Ab½ ; ð9Þ
for five “true” KD values in the range 0.5–100 nM. The resultant log–log linear
regression of true vs. apparent KD values was used to correct the ELISA KD
results (Fig. 1).3. Results
3.1. Unconjugated polyclonal rabbit anti-fibrin(ogen)(PA-fgn)
3.1.1. Radioimmunoassay (RIA) data
The nonspecific binding (NSB) of labeled fibrinogen to
gamma globulin in the absence of primary antibody was large
Fig. 2. Determination of thermodynamic functions for unconjugated polyclonal rabbit anti-human fgn–fgn binding: RIA Data. (a) Saturation isotherm of fgn RIA data
at 4°C; hyperbolic fit [r=0.997; y=11.73x/(25.69+x)]. (b) Scatchard plot of data from a. (c) van't Hoff plot of fgn RIA data: linear regressions; circles are high-affinity
associations, inverted triangles are low-affinity associations. (d) B vs. logF plot for test of [n] validity; 4°C data.
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nature, being reduced to 11–30% by including 0.5 M sodium
chloride in the incubation buffer. The true NSB was shown to be
8–17% by addition of an excess of unlabeled fibrinogen (fgn) to
the incubation solution.
Plots of antibody-bound labeled fgn vs. increasing unlabeled
fgn added at all three temperatures (dose–response curves, not
shown) indicated competitive protein binding behavior, which
was found to be saturable (Fig. 2a). Scatchard plots (Fig. 2b) of
these data revealed two major affinity ranges: high (in the order
of 108 M−1) and low (in the order of 106–107 M−1)(Table 1).Table 1
Unconjugated anti-fibrin(ogen)/fibrinogen binding characteristics
RIA
Temperature
(°C)
Kassoc
(M−1)
No. bind. sites/
Mol. Ab
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole
4 5.77×108 0.77 −4.65 −11.10 +23.31
6.06×107 2.12 −11.93 −9.86 −7.46
24/23 4.55×108 0.44 −4.65 −11.77 +23.97
2.02×107 1.78 −11.93 −9.93 −6.73
37 2.23×108 0.49 −4.65 −11.84 +23.21
5.80×106 5.26 −11.93 −9.59 −7.53The accuracy of high-affinity determinations below the first
unlabeled fgn standard (5.0 μg) was verified (at 37 °C) by
repeating the determinationb10 μg with two additional stan-
dards (1.0 and 2.0 μg). The plot was linear and the resultant
Kassoc of 2.60×10
8 M−1 agreed well with the value of
2.23×108 M−1 derived from the B0 and 5 μg fgn points.
Antibody occupancy (number of binding sites per molecule
antibody) significantly exceeded two only for the lowest affinity
interaction at 37 °C, indicating that nonspecific associations
began to predominate under those conditions. Klotz [43] had
cautioned that the concentration of ligand binding sites [n]ELISA
°)
Apparent Kassoc
(M−1)
“True” Kassoc
(M−1)
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
5.55×107 8.59×107 −1.05 −10.06 +32.50
4.56×107 7.80×107 −1.05 −10.69 +32.55
3.65×107 7.00×107 −1.05 −11.13 +32.50
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data. Based on his recommendation, a plot of B vs. logF for the
4 °C data (Fig. 2d) shows that the inflection point had clearly
been passed and occurred at about 6 nM bound fgn. The
maximum n of 14.1 nM fgn bound is more than twice this value.
Inflection points were even more clearly seen on analogous
plots of data obtained at higher temperatures (not shown).
Van't Hoff plots of the data (Fig. 2c) revealed moderate
negative enthalpy changes for the high-affinity interactions and
high negative enthalpy changes for the low-affinity interactions.
Standard entropy changes derived from these parameters (which
agreed well with values calculated from the y-intercept of the
van't Hoff plots) were highly positive for the high-affinity
interactions and moderately negative for the low-affinity
interactions (Table 1), supporting the conclusion that the high
affinities describe a specific Ab–Ag association in which
hydrophobic interactions play a prominent role, while the lower
affinities reflect a “nonspecific” ionic interaction.
3.1.2. Enzyme-linked immunosorbent assay (ELISA) data
The ELISA data for the unconjugated PA-fgn illustrate that
the resultant net optical densities at 405 nm define a hyperbolicFig. 3. Determination of thermodynamic functions for unconjugated polyclonal rabbit
all three temperatures; circles, solid line: 4 °C; circles, dotted line: 23 °C; inverted tr
y=0.974x/(2.767+x)]. (c) Linear transform (reciprocal plot) of data from b, quadra
ELISA affinities.relation (Fig. 3b) that is basic to the analysis of Edgell et al. [32].
The reciprocal plots of the dose–response data (Fig. 3c) are non-
linear, as expected for a polyclonal Ab preparation. The extrema
of these plots are in the range of 106 and 107–8 M−1, suggesting
that the strong nonspecific IgG-fibrin(ogen) association also
contributed to the ELISA results, since the background
correction involved nonspecific Ab binding to albumin. This
hypothesis seems to be supported by the ELISA-derived
average corrected affinities, which lay between the RIA extrema
(Table 1). The arithmetic average of the extrema, in fact, were
consistently in very good agreement with the SPHR-derived
value. The standard enthalpy (ΔH°) and entropy (ΔS°) changes
calculated from these affinities are more characteristic of
hydrophobic interactions than those of the higher RIA affinities,
however, rather than being intermediate between the two types
of interactions.
3.2. ELIP-conjugated PA-fgn
3.2.1. RIA data
125I-IgG radiotracer methodology enabled us to estimate the
antibody yields at each stage of the conjugation procedure: 80%anti-human fgn–fgn binding: ELISA data. (a) Semi-log dose–response curves at
iangles, dashed line: 37 °C. (b) Dose response at 4 °C, hyperbolic fit [r=0.990;
tic fit [r=0.996; y=0.860x2+0.045x+1.518]. (d) van't Hoff plot of corrected
Fig. 4. Determination of thermodynamic functions for EGIL-conjugated polyclonal rabbit anti-human fgn–fgn binding: RIA Data. (a) Saturation isotherm of fgn RIA
data at 26 °C; hyperbolic fit [r=0.996; y=6.892x/(127.3+x)]. (b) Scatchard plot of RIA data at 4 °C. (c) van't Hoff plot of Afgn-EGIL RIA data: linear regressions;
circles are high-affinity associations, inverted triangles are low-affinity associations. (d) B vs. logF plot for test of [n] validity; 37 °C data.
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separation of reduced thiolated protein; and 3.9% of starting Ab
finally coupled to ELIP. CoulterMultisizer analysis of PAfgn-ELIP
indicated a yield of 8.2×109 liposomes, exhibiting a number-
average diameter of 854 nm. The conjugation efficiency (CE),
therefore, was 1.35×104 Ab molecules per liposome, or
8.1 μg Ab/mg lipid. Based on an area of 11.34 nm2 subtended
by the Fc portion of IgG [44], Ab molecules would cover 66%
of the available liposomal surface area occupied by PE.Table 2
Anti-fibrin(ogen)-conjugated ELIP/fibrinogen binding characteristics
RIA
Temperature
(°C)
Kassoc
(M−1)
No. Site/
Lipsm. ×10−3
% Total
Ab
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mo
4 7.81×108 2.21 16.4 −1.90 −11.27 +33.81
4.23×106 103 766 +5.99 −8.40 +51.92
26/20 5.13×108 2.65 19.6 −1.90 −11.92 +33.48
1.30×107 26.7 198 +5.99 −9.73 +52.57
37 5.73×108 2.69 19.9 −1.90 −12.42 +33.93The fgn association behavior of ELIP-conjugated PA-fgn,
which also fell into two major affinity ranges, was in many
respects very similar to that of the unconjugated Ab (Fig. 4,
Table 2). While the highest affinity specific interactions
involved less than 20% of the available Ab, the lower affinity
associations far exceeded the conjugated Ab, indicating that
they were dominated by nonspecific interactions. Plots of B vs.
logF (Fig. 4d) confirmed the accuracy of Ab occupancy
information. As in the case of the unconjugated Ab, the specificELISA
le°)
Apparent
Kassoc (M
−1)
“True”
Kassoc (M
−1)
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
4.35±
0.72×107
7.61±
0.61×107
−0.37±1.20 −9.99 ± 0.04 +34.84±4.42
6.60±
3.20×107
9.15±
2.16 ×107
−0.37±1.20 −10.66 ±0.13 +35.24±4.53
4.24±
2.73×107
7.28±
2.16 ×107
−0.37±1.20 −11.13±0.17 +34.83±4.41
Fig. 5. Determination of affinities for EGIL-conjugated polyclonal rabbit anti-
human fgn–fgn binding: ELISA Data. (a) Dose–response curves for four
different EGIL preparations. (b) Linear transforms (reciprocal plots) of data
from a, linear regressions.
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entropy increase was about 10 cal/mole° higher (Table 2). The
thermodynamic properties of the low-affinity interactions,
however, appear to be radically different, having become endo-
thermic with a very high positive entropy change, suggesting a
liposomal contribution to the Ab–Ag binding energetics.
3.2.2. ELISA data
Four different PAfgn-ELIP preparations were assayed and
analyzed, resulting in corrected affinities and thermodynamic
functions that exhibited relatively low variance (Table 2).
Unlike the unconjugated Ab, the reciprocal plots for Ab-ELIP
were linear (Fig. 5b), but – like the unconjugated Ab – the
affinities were intermediate between the RIA extremes, whileTable 3
Unconjugated monoclonal anti-fibrin(ogen)/fibrinogen binding characteristics
RIA
Temperature
(°C)
Kassoc
(M−1)
No. Bind. Sites/
Mol. Ab
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole
4 2.15×108 1.34 −7.53 −10.56 +10.95
24/23 1.27×108 1.39 −7.53 −11.01 +11.74
37 4.73×107 1.43 −7.53 −10.89 +10.84the ΔH° and ΔS° values were similar to the corresponding
functions for the high-affinity RIA data, as well as for the
unconjugated Ab ELISA data.
3.3. Unconjugated monoclonal anti-fibrin(ogen)(MA-fgn)
3.3.1. RIA data
A single Kassoc was determined by linear regression analysis
at each temperature (r=−0.934 to −0.971) and was in the range
107–8 (Table 3). The three Scatchard plots converged at an Ab
occupancy of 1.39±0.03 binding sites per molecule Ab. The
MAb affinities and occupancy values were intermediate be-
tween those of two major classes of PAb reported above. The
thermodynamics of MAb binding, featuring a relatively large
negative enthalpy and a moderate positive entropy (Table 3),
indicate that the MAb utilizes a combination of several types of
noncovalent interactions to bind fgn.
3.3.2. ELISA data
The reciprocal plots were linear; affinities calculated from
the ELISA data were very similar to those calculated from the
RIA data (Table 3), but with a shallower slope vs. temperature,
resulting in about half the exothermic enthalpy increment. Like
the unconjugated PA-fgn, the ELISA-derived ΔS° was
appreciably greater than the RIA-derived value.
3.4. ELIP-conjugated MA-fgn
3.4.1. RIA data
MAfgn-ELIP comprised 3.31×1010 recovered ELIP (dn=
637 nm) conjugated to 41.8 μg Ab, resulting in a CE of
5.07×103 molecules per liposome or 4.3 μg Ab/mg lipid; 56%
of available PE was coupled to Ab. The predominant higher-
affinity Ab–Ag interactions were lower than the unconjugated
MA-fgn and included nonspecific associations that supersatu-
rated the available EGIL surface Ab (Table 4). Like the average
of specific and nonspecific PAfgn–ELIP associations, these
interactions were characterized by positive enthalpies and very
high positive entropies.
3.4.2. ELISA data
As with the unconjugated MAb, the reciprocal plots were
linear. In this case, the affinities determined by ELISA were
strikingly disparate from those found by RIA, being two orders
of magnitude higher. Yet, the ΔH° and ΔS° values were very
similar to the corresponding functions for the RIA data
(Table 4).ELISA
°)
Apparent Kassoc
(M−1)
“True” Kassoc
(M−1)
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
8.42×108 3.23×108 −3.52 −10.78 +26.21
4.91×108 2.48×108 −3.52 −11.37 +26.50
2.02×108 1.61×108 −3.52 −11.64 +26.18
Table 4
Monoclonal anti-fibrin(ogen)-conjugated ELIP/fibrinogen binding characteristics
RIA ELISA
Temperature
(°C)
Kassoc
(M−1)
No. Site/
Lipsm.×10−3
% Total
Ab
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
Apparent Kassoc
(M−1)
“True” Kassoc
(M−1)
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
4 1.08×107 32.6 642 +3.05 −8.91 +43.19 5.65×109 8.19 ×108 +1.61 −11.30 +46.60
25/23 1.23×107 21.9 433 +3.05 −9.67 +42.67 7.69×109 9.52 ×108 +1.61 −12.16 +46.52
37 2.05×107 15.4 303 +3.05 −10.37 +43.29 1.07×1010 1.12 ×109 +1.61 −12.84 +46.60
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3.5.1. Unconjugated MA-fgn Fab
The characteristics of Fab–fgn interactions are summarized
in Table 5. Whereas a single Kassoc was found at each tem-
perature for MAfgn–fgn interactions, up to two were found for
the Fab. The higher Kassoc values at 4 and 25 °C (indiscernible
at 37 °C) were similar to the corresponding values for MAfgn,
suggesting that the lower Kassoc values represent unusually
strong nonspecific interactions. This possibility is supported by
high binding of 125I-fgn to Fab in the presence of 100 μg
unlabeled fgn (∼25%). The Scatchard plots (not shown) in-
dicate, based on the occupancy data ([n]), that 4–5 Fab
molecules bind to each fgn molecule specifically, while 2–3 Fab
associate with each fgn molecule nonspecifically. The thermo-
dynamic profiles of the putative nonspecific interactions are
now more indicative of hydrophobic interactions, suggesting
that removal of the Fc fragment may have exposed apolar
residues. Although the specific affinities are similar to those of
the parent MAb, the thermodynamic profile is more character-
istic of an ionic interaction, suggesting that the proteolytic
cleavage may have caused an allosteric modification of the
antigen-binding site.
3.5.2. ELIP-conjugated MA-fgn Fab
MAfgn Fab-ELIP comprised 1.28×1010 recovered ELIP
(dn=1,030 nm) conjugated to 48.0 μg Fab, resulting in a CE of
5.14×104 molecules per liposome or 5.0 μg Fab/mg lipid
(8.5 μg Ab equivalent/mg lipid); 61% of available PE was
coupled to Fab. Only the highest affinities at each temperature
represent specific interactions, involving virtually all of the
liposomal Fab (Table 5). Nonspecific binding to the liposomesTable 5
Monoclonal anti-fibrin(ogen) Fab/fibrinogen binding characteristics — RIA data
Unconjugated
Temperature
(°C)
Kassoc
(M−1)
No. Bind. Sites/
Mol. Fab
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
4 3.06×108 0.23 −10.44 −10.75 +1.13
8.11×107 0.38 −7.50 −10.02 +9.12
25/26 8.56×107 0.21 −10.44 −10.82 +1.26
2.02×107 0.43 −7.50 −10.12 +8.80
37 2.02×107 0.35 −7.50 −10.36 +9.24involved more than eightfold greater amounts of fgn, exceeding
by more than threefold the theoretical maximum amount of
surface area available for fgn binding (based on known end-on
dimensions of the fgn molecule). These findings suggest that
Ag–Ag interactions may also be involved in nonspecific
binding of fgn to EGIL. The affinity of the specific interactions
was 2–6 times higher than that found for the higher affinity
MAfgn-ELIP/fgn associations (Table 4), which seem to
correspond to the mid-range Fab affinities, suggesting that the
highest affinity interactions were not detected for the MAfgn-
ELIP. As was the case for intact MAb, significant increases in
ΔH° and ΔS° (in the positive direction) were seen upon ELIP
conjugation of Fab, but the interaction remained exothermic in
this instance (Table 5).
3.6. Monoclonal anti-fibrin (ELISA data only)
3.6.1. Unconjugated MA-fb
A great advantage of ELISA relative to RIA in this case is
that it permits study of solid-phase fibrin systems that better
approximate the intended application of fibrin-specific anti-
bodies. An ELISA analysis of one such Ab is summarized in
Table 6. All reciprocal plots for both the unconjugated Ab and
Ab-ELIP were linear, with rN0.95. The affinities and
thermodynamic functions of the unconjugated MA-fb were
very similar to those of the PA-fgn determined by ELISA
analysis (Table 1), being indicative of strong hydrophobic
interactions.
3.6.2. ELIP-Conjugated MA-fb
ELIP conjugation of the Ab decreased the affinities by
little more than one-half, with only minor changes in theConjugated
Kassoc
(M−1)
No. Site/
Lipsm. ×10−3
% Total
Ab
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
6.93×107 46.2 89.8 −2.04 −9.94 +28.51
1.35×107 195 379 −2.22 −9.04 +24.61
5.98×106 377 733 −1.55 −8.59 +25.39
5.23×107 62.0 121 −2.04 −10.56 +28.49
9.98×106 233 454 −2.22 −9.60 +24.60
4.70×107 59.0 115 −2.04 −10.88 +28.52
4.45×106 425 826 −1.55 −9.43 +25.40
Table 6
Monoclonal anti-fibrin/fibrin binding characteristics — ELISA data
Unconjugated Conjugated
Temperature
(°C)
Apparent Kassoc
(M−1)
“True” Kassoc
(M−1)
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
Apparent Kassoc
(M−1)
“True” Kassoc
(M−1)
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
4 1.22×108 1.26×108 −2.73 −10.27 +27.20 1.45×107 4.47×107 −2.89 −9.70 +24.57
23 1.16×108 1.23×108 −2.73 −10.96 +27.79 1.42×107 4.41×107 −2.89 −10.35 +25.21
37 3.80×107 7.14×107 −2.73 −11.14 +27.12 4.30×106 2.45×107 −2.89 −10.48 +24.48
1711M.E. Klegerman et al. / Biochimica et Biophysica Acta 1768 (2007) 1703–1716thermodynamic functions. Unlike previous Abs studied, the
functions became less hydrophobic in nature after conjugation
(Table 6).
3.7. PA-fgn in serum (ELISA data only)
3.7.1. Unconjugated PA-fgn
The affinity of unconjugated Ab binding to fibrinogen in
NRS was at least as great as found by ELISA, using PBS-T as
diluent, being 16 to 69% higher than previously found (Tables 1
and 7) over the temperature range studied. Although the
interaction was now endothermic, there was no appreciable
enthalpy change in either case and the difference may not be
significant. Likewise, the entropy increments were within the
same range (+32–40 cal/mole°).
3.7.2. ELIP-conjugated PA-fgn
The affinities and thermodynamic functions of PAfgn-ELIP/
fgn in NRS fell well within the analogous populations (PN0.1)
of four other PAfgn-ELIP preparations in PBS at two
comparable temperatures (4° and 37 °C; Tables 2 and 7).
3.8. Relation of thermodynamic function increments to
phospholipid phase transitions
In order to test the hypothesis that differences in ΔH° and
ΔS° of Ab–Ag association after conjugation of Ab to ELIP are
caused by linkage of the binding to the energetics of the PE
gel–liquid crystal phase transition, the thermodynamic function
increments were plotted against each other as percentages of
published ΔH° (+8.71 kcal/mole) and ΔS° (+25.8 cal/mole°)
values [45] for the transition in dipalmitoyl PE (Fig. 6). The plot
demonstrates an excellent correlation, with a slope that does not
differ significantly from 1.0 (PN0.05), supporting the hypothesis.
To determine whether coupling of transition energetics to Ab–Ag
association kinetics was dependent on the type of interaction,
ΔH° or ΔS° of the unconjugated Ab–Ag interaction was plottedTable 7
Polyclonal anti-fibrin(ogen)/fibrinogen binding characteristics in rabbit serum — EL
Unconjugated
Temperature
(°C)
Apparent Kassoc
(M−1)
“True” Kassoc
(M−1)
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mo
4 7.38×107 9.94×107 +0.86 −10.14 +39.69
25 7.60×107 1.08×108 +0.86 −10.95 +39.64
37 1.07×108 1.18×108 +0.86 −11.45 +39.70relative to the corresponding percent function change of the
transition (Fig. 7), which varied from a fractional exothermic
liquid crystal→gel transition to the endothermic molar contri-
bution of two PE molecules undergoing the phase transition.
Significant inverse correlations (r∼0.85, P≤0.02) were seen for
bothΔH° andΔS°, suggesting that coupling is a function of ionic
interactions. Data derived from PA-fgn/fgn interactions in normal
rabbit serum (NRS) exhibited the same relationships in both plots
as data derived from Ab–Ag interactions in non-serum contain-
ing diluents.
4. Discussion
4.1. Binding of unconjugated antibodies to human fibrinogen
and fibrin
4.1.1. RIA studies elucidate nonspecific interactions
In this study, we have demonstrated two general classes of
noncovalent interactions between polyclonal antibodies (PA-
fgn) and human fibrinogen at three temperatures, utilizing
standard RIA methodology followed by Scatchard and van't
Hoff analyses. The higher affinity associations, in the order of
108 M−1, were characterized by Ab occupancies of less than
one fgn binding site per molecule Ab and were dominated by
hydrophobic interactions, indicating a specific Ab–Ag associ-
ation. The lower affinity associations, in the order of 106–
107 M−1, were characterized by Ab occupancies generally
greater than two fgn binding sites per molecule Ab, were
appreciably exothermic and exhibited negative ΔS°, suggesting
nonspecific interactions dominated by ionic attractive forces.
Specific fgn binding by a mouse monoclonal anti-fibrinogen Ab
(MA-fgn) could be attributed more to ionic and hydrogen bond
contributions, while removal of the Fc portion of the MA-fgn
Ab appeared to shift specific binding to a more ionic character
and produced a hydrophobically-driven nonspecific association.
A relatively high-affinity (∼6×106 M−1 at 37°C) nonspecific
association between fibrinogen and immunoglobulins (Ig) wouldISA data
Conjugated
le°)
Apparent Kassoc
(M−1)
“True” Kassoc
(M−1)
ΔH°
(kcal/mole)
ΔG°
(kcal/mole)
ΔS°
(cal/mole°)
3.33×107 6.69×107 −0.31 −9.92 +34.69
8.17×106 3.37×107 −0.31 −10.26 +33.41
4.05×107 7.36×107 −0.31 −11.16 +35.00
Fig. 6. Correlation of standard enthalpy and entropy increments upon Ab-EGIL
conjugation relative to corresponding values for the PE gel–liquid crystalline
phase transition (r=0.990, y=1.095x−3.17, Sb=0.047); circles: RIA data,
triangles: ELISA data; filled symbols: PBS-T/PBS diluent, open symbol: normal
rabbit serum (NRS).
Fig. 7. Interaction dependence of PE major phase transition coupling of Ab–Ag
association energetics. Circles: X=H (kcal/mole), triangles: X=S (cal/mole°);
filled symbols: RIA data, open symbols: ELISA data; large symbols: NRS.
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concentrations of fgn and Ig, fgnwould be completely adsorbed to
Ig, while∼3% of Ig would be bound to fgn, creating a “reservoir”
functional quality, including relatively slow depletion kinetics, for
fgn that is characteristic of effectors possessing carrier proteins.
Since fgn affinity for Ig is about one order of magnitude higher
than its strongest binding to thrombin [46], the fibrinopeptide
cleavage sites of fgn would have to be fully exposed while bound
by Ig. Despite its implications, there have been relatively few
reports of this phenomenon. In serum, all fgn migrates
electrophoretically as a β/γ globulin and, in fact, is located at
the anodal edge of the γ-globulin zone [47], which would be
expected for a more anionic protein complexed with Ig. Davey
et al. [48] concluded that nonspecific protein interactions were
responsible for prolongation of thrombin and reptilase clotting
times in normal plasma and fgn solutions caused by addition of
purified gamma globulin.
Recently, Ben-Ami et al. [49] reported indirect evidence
(quantitation of red blood cell aggregation) for the formation of
ternary complexes of Ig, fgn and albumin in vitro and in vivo.
Such complex formation could have occurred in the RIA, since
the diluent used for both primary and secondary incubations
contained albumin, although concentrations of both albumin
(0.35%) and fgn in the assay were well below threshold levels
required for observable RBC aggregation. If ternary complex
formation occurred, the lower affinity interactions observed in
this study would describe binding of fgn to albumin that was, in
turn, bound to Ig.
4.1.2. ELISA analysis can provide suitable binding data if
potential artifacts are eliminated
Binding affinities corrected for shifting equilibria during a
secondary Ab incubation were consistently closer to the RIA
values than the uncorrected affinities. Although the lowest
affinity interactions calculated from non-linear reciprocal plots
of PA-fgn binding to immobilized fgn were in the range of
nonspecific binding in the RIA, it is likely that the use of netA405 eliminated nonspecific associations from consideration in
the ELISA. The reciprocal plots were consistently linear for
MAb, which would not be expected if contributions from lower
affinity nonspecific interactions were present. If ternary
complexes of fgn, Ig and albumin do form, albumin may have
adsorbed to immobilized fgn, as well as to unoccupied sites on
the plastic matrix, during the blocking step, but Tween 20 in the
diluent would have precluded nonspecific binding of Ab during
subsequent incubations. Any Ab binding to adsorbed albumin
would have occurred in background wells and would have been
subtracted from the total OD, hence being eliminated from
consideration. It is more likely, therefore, that the lower affinity
binding seen in non-linear reciprocal plots truly represents
lower affinity specific Ab interactions with fgn in PAb
preparations.
For PA-fgn and MA-fgn, ΔH° and ΔS° calculated from
ELISA data were consistently higher than the values calculated
from RIA data, suggesting a greater contribution from
hydrophobic interactions in the ELISA. This observation is
consistent with numerous reports of decreased immunoreactiv-
ity of protein antigens adsorbed to microtiter wells due to partial
denaturation on hydrophobic surfaces [50,51]. The microplates
used for this study were relatively hydrophobic and molecular
rearrangements of fgn during adsorption to the plastic may have
exposed apolar residues that would be inaccessible in aqueous
solution. The endothermic shift caused by this process was
largely offset by the entropic contribution, resulting in a
relatively small change in the binding affinity. This study,
therefore, demonstrates the suitability of ELISA methodology
for molecular characterization of Ab–Ag associations, provided
that potential sources of bias are taken into account.
4.2. Binding of immunoliposomes to human fibrinogen and
fibrin
4.2.1. RIA analysis revealed remarkable changes in
thermodynamic functions after Ab conjugation to ELIP
Upon conjugation of Ab to ELIP, a striking, consistent
increase in ΔH° and ΔS° for both specific and nonspecific
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association constants remained about the same or decreased by
approximately one order of magnitude, resulting from the
contribution of changed ΔH° and ΔS° values to ΔG°.
4.2.2. ELISA analysis of additional EGIL preparations
indicated variability of binding behavior after conjugation of
ELIP to different Abs, but consistency among replicate
conjugates of a single Ab
This series of experiments not only permitted comparison of
RIA and ELISA data, but also different EGIL lots employing
the same Ab, since separate conjugations were performed for
RIA and ELISA analyses. For PA-fgn, the RIA-derived
affinities of specific interactions were one log higher, and for
MA-fgn nearly two logs lower, than association constants
calculated from ELISA data, while ΔH° and ΔS° determined
by the two methods were similar (dΔH°b2 kcal/mole, dΔS°b
4 cal/mole°), indicating that relatively small differences in the
thermodynamic functions describing the interactions could
result in large differences in affinities because of their relative
contributions to ΔG°. Based on ELISA data, Ab conjugation to
ELIP produced a variety of responses in affinities and
thermodynamic functions, ranging from the marked increments
of ΔH° and ΔS° observed by RIA analysis (for MAfgn-ELIP)
to relatively small differences of the functions (for PAfgn- and
MAfb-ELIP). Changes in affinities were within one order of
magnitude. It would be expected that the intrinsic affinities
measured by ELISA are the same as those determined by RIA,
because dissolution of the liposomal membrane by PBS-T
following the primary incubation enables the same stoichio-
metric association of the secondary Ab–AP conjugate with
primary Ab as with unconjugated Ab.
4.3. Possible coupling of association energetics to
phospholipid phase transitions
Changes in thermodynamic functions following ELIP
conjugation of the antibodies studied could have been caused
by an interaction between the phospholipid hydrocarbon side
chains and possibly denatured fgn domains, but no net free
energy decrease would be expected in such an interaction. It is
more likely that the observed ΔH° and ΔS° increments
represent a connection between the PE gel–liquid crystal
phase transition and the Ab–fgn interaction, especially since the
characteristic ratio ofΔH° toΔS° is maintained in every case. A
perturbation of PE acyl chain conformation may be driven by
the enthalpy of Ab–Ag association, since the correlation ofΔX°
vs. percent PET was stronger for ΔH° than for ΔS° and
exothermic–endothermic reaction coupling, such as that
involving the hydrolysis of high-energy anhydride bonds,
occurs often in protein interactions.
Giehl et al. [52], in their differential scanning calorimetric
(DSC) study of GM2 activator protein interactions with
liposomes, concluded that a Tc decrease caused by nonspecific
binding could be attributed to destabilization of the gel phase by
perturbations in the head group region of the bilayer transmitted
to the hydrocarbon chains. It is well established that allostericeffects, such as hemoglobin cooperativity [53,54] and RecA
protein-induced DNA strand exchange [55], often involve
transmission of the favorable ΔG of noncovalent interactions to
remote protein sites, where work is performed as mechanical
translocation or structural destabilization. This energy trans-
duction effect frequently manifests as changes in the affinity of
noncovalent associations.
Although predicted by the deduced energetics of allosteric
effects, a triggering of phospholipid phase transitions by
noncovalent associations, which reciprocally alter the interac-
tion affinity, may be a somewhat novel observation. In this
regard, the covalent PE–Ab linkage, consisting of an α-amino-
methylthio-p-maleimidophenylbutyryl moiety having a pro-
nounced π-electronic character, may substantially increase the
transduction efficiency between the Ab and the lipid chains.
Discrete ionic interactions between Ab and fgn at the site
of the Ab epitope are apparently required for transduction
to occur, since transduction efficiency correlated well with
the ionic character of the interaction and a maximum PE
contribution of two moles was seen. Such an occurrence is
plausible, considering the likelihood that each fgn mole-
cule subtends (and presumably perturbs) about ten PE head
groups and transduction would be expected to involve electron
translocations.
It is unlikely, however, that Ab–Ag association provokes
PE melting, since the ELIP formulation, which contains egg
PC (half oleylated) and cholesterol, is in the liquid crystalline
phase throughout the temperature range studied. In addition,
we found by DSC analysis that the Tc of MPB-PE is 17 °C
(Kee, P. and Klegerman, M.E., unpublished data), probably
because the bulky head group inhibits acyl chain packing.
Furthermore, the thermodynamic function increments observed
suggest transmission of PE freezing energetics, which are
exothermic, to the Ab binding site. It is possible that
transmission of the exothermic Ab–Ag binding enthalpy
through PE head groups disrupts van der Waal's contacts
between the PE palmitoyl carbons and surrounding acyl chains
formed during a putative re-stabilization in the liquid
crystalline phase. Transient re-freezing of the PE palmitoyl
chains would then be energetically favored at 4–37°C (−1.56
to −0.71 kcal/mole).
Independent testing of the hypothesis that PE gel–liquid
crystal phase transitions underlie the thermodynamic character-
istics of fgn binding by Afgn-EGIL is problematic. The most
direct approach involves microcalorimetric analysis, which
permits direct measurement of Ab–Ag association enthalpy
increments, as well as association effects on the PE phase
transition. The former measurement, employing EGIL at
maximum achievable conjugation efficiencies, would yieldb10
μcal, which is below the sensitivity of existing DSC technology.
The latter measurement would be even more unfeasible, being
in the ncal range. We have verified the unfeasibility of both
measurements by DSC analysis (Kee, P. and Klegerman, M.E.,
unpublished data). DSC analysis utilizing small-molecular
model systems appears to be the most promising avenue for
testing of the hypothesis and verification of the results found in
these studies.
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that Ag binding to Ab-ELIP provokes clustering of Ab-S-PE
molecules in the liposomal membrane. On the one hand, a local
freezing of acyl chains may be induced, as required by the
proposed transduction mechanism; on the other hand, an
unfavorable ΔH° may be caused by mutual repulsion of
negatively charged head groups (the PE amino function is
covalently linked to a sulfur atom), while a positive ΔS° could
result from liberation of counterions, with the attendant
disordering of water. These hypotheses, dependent upon global
liposomal effects, are contradicted, however, by our finding that
the characteristic correlations among thermodynamic values are
maintained by EGIL interactions in PBS-T (data not shown),
suggesting that the relationships reflect intrinsic properties of
the Ab-PE conjugate.
4.4. Implications for EGIL optimization
All Ab–Ag binding characteristics studied for the PA-fgn/
fgn interaction were virtually unaffected in the presence of
undiluted serum. This remarkable finding not only tends to
confirm the robustness of the methodological approach
employed, but also indicates that the information derived
from it is fully applicable to development of EGIL technology
for clinical use.
Rapid clearance of targeted particulates, including immuno-
liposomes, by the lymphoreticuloendothelial system (LRES)
has often been encountered in vivo, resulting in extensive
attempts to formulate “stealth” technologies that feature
covalent conjugation of polyethylene glycol (PEG) to the
particles. Targeting of the stealth micro- and nanoparticles can
then be accomplished by coupling antibodies and other ligands
to derivatized PEG molecules. Although our EGIL formulation
has not been chemically protected from LRES sequestration, we
have been able to demonstrate effective targeting in a Yucatan
miniswine atherosclerosis model after local administration
under clinically relevant conditions [38]. Furthermore, we
have demonstrated significant (23–31%) enhancement of left
ventricular thrombus visualization by epicardial and transtho-
racic ultrasound imaging in dogs after intravenous administra-
tion of PAfgn-ELIP [56]. Thus, full retention of EGIL Ab–Ag
binding characteristics in the presence of undiluted normal
rabbit serum is entirely consistent with previous observations in
vivo using these same EGIL preparations.
The construction of a circulating flow chamber, in which
physiologic conditions of constant or pulsatile flow could be
simulated [39], has enabled us to assign a quantitative criterion
for optimal EGIL fibrin-targeting efficiency (TE). That criterion
is 80% retention of radiolabeled EGIL on a fibrin-impregnated
filter paper disk after 60 min at a temperature of 25°C and a
shear stress of 15 dyn/cm2. Optimal targeting was observed for
PAfgn-EGIL and MAfgn Fab-EGIL, but not for MAfgn-EGIL
and PAfgn-EGIL made with half the customary amount of Ab.
Seeking an affinity-dependent parameter that is predictive of
optimal TE, we found that the number-dependent avidity,
summing all the observed affinities as a product of conjugated
Ab number per liposome, which can only be determined by RIAanalysis (or other method that permits Scatchard analysis of
soluble reactants), correlated well with the flow circuit results
(Klegerman, M.E., unpublished data). The avidity threshold for
optimal TE was 2×1012 M−1 liposome−1. An avidity index that
utilizes the maximum information regarding Ag binding
obtainable by ELISA analysis, i.e., the sum of all observed
affinities expressed as a product of conjugation efficiency (CE),
reflecting only specific interactions instead of the actual number
of interactions, yielded a much poorer correlation. These results
imply that knowing the total ligand concentration available for
binding at each Kassoc ([n]) is critical to accurate assessment of
TE and that nonspecific interactions contribute significantly to
EGIL targeting. It is likely, in fact, that specific interactions
between EGIL and fibrin in vivo will be stabilized by
nonspecific interactions having affinities only about one order
of magnitude less, but occurring at appreciably more numerous
sites. Thus, the avidity of nonspecific interactions could equal
or exceed that of specific Ag binding.
Even though the underlying mechanisms deduced are
presently unsubstantiated, the observed correlations among
thermodynamic values permit the prediction of EGIL affinities
from the ΔH° and ΔS° of unconjugated Ab binding to Ag. The
utility of this approach to EGIL optimization may be limited by
large impacts on association constants by relatively small
variations about the regression lines, as noted above. The
feasibility of this predictive approach will be tested in future
studies.
4.5. Conclusions
The binding of unconjugated and ELIP-conjugated A-fgn to
fgn has been studied by two independent methods, RIA and
ELISA. Generally, the binding affinities and thermodynamic
functions, ΔH° and ΔS°, calculated from data generated by
these methods were in good agreement, with the exception of
deviations that could be readily ascribed to known factors. A
relatively high-affinity ionic interaction between fgn and Ig,
characteristic of these proteins, was detected and elucidated by
RIA, but not by ELISA. The correspondence of specific binding
characteristics determined by the two methods further served to
confirm the results. The nonspecific interactions appeared to
increase the likelihood of effective EGIL targeting in vivo,
which has been demonstrated in several previous studies.
Replication of Ab–Ag binding affinity and thermodynamic
characteristics in undiluted normal rabbit serum tends to
validate the use of the methodological approach for clinical
optimization of EGIL technology. Finally, this study has
provided evidence for energy coupling between non-covalent
Ab–Ag associations and EGIL phospholipid phase transitions,
a phenomenon that may define a new level of immunoliposome
utility and control, as well as novel nanotechnological
applications.
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